VistaGen Therapeutics Inc. (NASDAQ: VTGN)
$2.7650
+0.1850 ( +7.17% ) 159.9K
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.
Market Data
Open
$2.7650
Previous close
$2.5800
Volume
159.9K
Market cap
$77.29M
Day range
$2.5700 - $2.7850
52 week range
$2.4800 - $5.8600
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | Aug 13, 2024 |
10-q | Quarterly Reports | 58 | Aug 13, 2024 |
def | Proxies and info statements | 26 | Jul 17, 2024 |
8-k | 8K-related | 16 | Jul 12, 2024 |
8-k | 8K-related | 16 | Jul 10, 2024 |
4 | Insider transactions | 1 | Jul 02, 2024 |
4 | Insider transactions | 1 | Jul 02, 2024 |
4 | Insider transactions | 1 | Jul 02, 2024 |
4 | Insider transactions | 1 | Jul 02, 2024 |
8-k | 8K-related | 16 | Jun 28, 2024 |